ReGeleTec

ReGeleTec is a clinical-stage medical device company focused on developing next-generation treatments for degenerative disc disease. The company's flagship technology, Hydrafil, is a percutaneous, injectable hydrogel designed to augment the nucleus pulposus of the spinal disc, restoring its biomechanical properties and relieving chronic low back pain. Unlike traditional invasive surgeries, ReGeleTec's solution offers a minimally invasive outpatient procedure that fills cracks and fissures in the disc. The company is currently advancing its clinical programs to provide a middle-ground treatment option between conservative care and major spinal surgery.